Is Prozac (Fluoxetine) Effective for Binge Eating Disorder?
Prozac (fluoxetine) is NOT recommended as a primary treatment for binge eating disorder, as it has not demonstrated superiority over placebo in reducing binge eating episodes and is not FDA-approved for this indication. 1, 2
FDA Approval Status and Evidence
- Fluoxetine is FDA-approved for bulimia nervosa (at 60 mg/day) but is not approved for binge eating disorder 1
- The FDA label for fluoxetine specifically indicates efficacy for "binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa" but makes no mention of binge eating disorder as an indication 1
Direct Evidence Against Fluoxetine for BED
- In a high-quality randomized controlled trial, fluoxetine 60 mg/day showed no superiority over placebo for binge eating disorder, with remission rates of only 22% (fluoxetine) versus 26% (placebo) in intent-to-treat analysis 2
- Fluoxetine alone failed to demonstrate efficacy for behavioral and psychological features of BED, though it is effective for bulimia nervosa 2
- When combined with cognitive behavioral therapy (CBT), adding fluoxetine provided no clear advantage over CBT alone 3
Recommended Treatment Approach
First-line treatment for BED should be psychotherapy, specifically cognitive-behavioral therapy (CBT) or interpersonal therapy 4, 5
When to Consider Medication
Medications should be considered when: 4, 5
- Patients prefer medication over psychotherapy
- Patients have not responded adequately to psychotherapy alone
- Comorbid obesity is present
FDA-Approved Medication Option
- Lisdexamfetamine is the only FDA-approved medication specifically for moderate-to-severe binge eating disorder and should be the first-line pharmacological choice when medication is indicated 6, 4
Alternative Medication Options (Off-Label)
If lisdexamfetamine is not appropriate, consider: 4, 5
- Topiramate - has substantial evidence for reducing binge eating behaviors
- Naltrexone/Bupropion - particularly useful for patients with food cravings or addictive eating patterns, or comorbid depression
Important Clinical Caveat
- While fluoxetine has modest short-term effects in some older studies showing reduction in binge frequency 7, 8, the most rigorous head-to-head comparison demonstrated it was not superior to placebo 2
- Avoid weight gain-inducing medications such as mirtazapine and tricyclic antidepressants in BED patients with obesity 4, 5